| Accession | PRJCA025578 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Title | Nucleic acid biomarker data in Phase III Clinical Study of Recombinant Human Coagulation Factor VIII | ||||||||
| Relevance | Medical | ||||||||
| Data types | Nucleic acid biomarker | ||||||||
| Organisms | Homo sapiens | ||||||||
| Description | A Multi-center, Open-label, Uncontrolled Phase III Clinical Study Evaluating the Efficacy, Safety and Pharmacokinetics in the Prophylactic Treatment of Recombinant Human Coagulation Factor VIII (SCT800) in Factor VIII Treated Children (< 12 Years) with Severe Haemophilia A | ||||||||
| Sample scope | Homo sapiens | ||||||||
| Release date | 2024-04-24 | ||||||||
| Grants |
|
||||||||
| Submitter | Xiaojing Qin (xiaojing_qin@sinocelltech.com) | ||||||||
| Organization | Sinocelltech, Ltd. | ||||||||
| Submission date | 2024-04-24 |
| Resource name | Description |
|---|